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Background
The primary objective o£ this study was to obtain performance capability measures for various classes of clinical laboratories in the United States and to determine if there are significant differences in analytical accuracy which would warrant remedial action by public agencies or tlie private sector.
The procedure utilized was to:
(1) establish a Scientific Advisory Committee of governmental and health industry representatives, (2) develop a survey design, (3) contact professional and regulatory groups to solicit laboratory participation, (4) The techniques used had a considerable effect on the accuracy and precision of reported analyses. Table 1 lists the techniques which were most satisfactorily applied and the percentage of the participating laboratories which applied each technique.
In most instances, automated methods were applied with equal or better average accuracy and considerably better precision than the corresponding manual methods. Results reported by laboratories using diagnostic kits were consistently less precise than other determinations. Insufficient information was available to assess the medical usefulness of the total bilirubin determinations. Of the remaining seven constituents, only cholesterol was analyzed by the study participants -with sufficient precision to permit the interlaboratory monitoring over time of the variation in an individual patient's constituent concentrations.
In contrast, reference laboratory analyses of cholesterol, uric acid, urea nitrogen, sodium and total protein were all sufficiently precise to permit interlaboratory monitoring of individual variation. Those participating laboratories using the best applied techniques also achieved acceptable interlaboratory precision in analyses of these five constituents.
Results -Hematology
As with clinical chemistry, the average laboratory results obtained by the participating groups did not differ significantly at the 951 confidence level. The interlaboratory precision of the laboratory groups can be exhibited as follows where groups joined by the same line did not exhibit significant differences at the 90% confidence level. Because all of the laboratories participated on a purely voluntary basis, no straightforward extrapolation can be made to the larger universe of unsampled clinical laboratories.
Rank
2.
It is probable that the results of this study do not represent routine laboratory performance for two reasons:
(a) a laboratory probably would not volunteer if its management felt that to do so would be disadvantageous, and (h) the sample materials probably received special attention in many of the smaller laboratories which were unfamiliar with analyzing proficiency test samples. The clinical chemistry test specimens were prepared by a dialyzation process which removes naturally occurring reducing agents and other substances. As a result, the accuracy of some methods, as applied to the test specimens, might differ from their accuracy in analyses of human serum.
4.
The true constituent concentrations of cholesterol and the hematology constituents could not be exactly determined. For these constituents accuracy was assessed relative to the mean reference laboratory assays. vii Executive summary of a report abstracted as follows: The proficiency of a selected sample of physician, hospital and independent laboratories was assessed with respect to their ability to analyze clinical chemistry and hematology samples and to identify microbiological organisms. For the assessment of clinical chemistry and hematology proficiency, the laboratories were grouped and determinations of group accuracy and group precision were made. Further analyses were performed to determine relative accuracy and precision of the techniques presently applied by these groups. There was no significant difference at the 951 confidence level in the accuracy achieved by the various laboratory groups involved in Clinical chemistry and hematology analysis.
Recommendat ions
In clinical chemistry, the MedicareCertified Independent Laboratories, CDC Tested Laboratories and JCAH-Members generally proved more precise than Physicians' Office and Medicare-Certified Hospital Laboratories. However, none of the laboratory groups were sufficiently accurate to permit the monitoring over time of variation in an individual patient's constituent concentrationf; It would appear that poor selection of techniques was an important contributor to this low performance level.
In hematology the Physicians' Office Laboratories proved to be the least precise of the groups. There was no noticeable difference in precision between participants in the CDC proficiency testing program and non-participants. With respect to microbiology, 7.6% of the identifications by laboratories 
